LRI Investments’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$64.2K Sell
1,505
-850
-36% -$46.2K 0.01% 519
2026
Q1
$148K Sell
2,355
-2,482
-51% -$199K 0.01% 340
2025
Q4
$461K Sell
4,837
-1,629
-25% -$160K 0.04% 184
2025
Q3
$631K Buy
6,466
+30
+0.5% +$3.11K 0.05% 161
2025
Q2
$691K Buy
6,436
+33
+0.5% +$3.34K 0.06% 144
2025
Q1
$646K Buy
6,403
+551
+9% +$55.5K 0.06% 143
2024
Q4
$523K Hold
5,852
0.05% 134
2024
Q3
$513K Sell
5,852
-40
-0.7% -$3.15K 0.05% 146
2024
Q2
$454K Buy
5,892
+5,741
+3,802% +$420K 0.05% 125
2024
Q1
$10.3K Buy
+151
New +$9.71K ﹤0.01% 502

Other funds holding BSX

LRI Investments's BSX Position: Q2 2026 in Review

LRI Investments reduced its Boston Scientific (BSX) stake by 36% in Q2 2026, selling an estimated $46.2K and leaving 1,505 shares worth $64.2K. The position accounts for 0.01% of the portfolio, ranked #519.

LRI Investments first reported a position in BSX in Q1 2024 and has held it in 10 quarters since. The position peaked at $691K in Q2 2025. 770 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • LRI Investments held 1,505 shares of Boston Scientific worth $64.2K as of Q2 2026.
  • LRI Investments sold 850 Boston Scientific shares in Q2 2026, an estimated $46.2K.
  • Boston Scientific made up 0.01% of LRI Investments's portfolio in Q2 2026, its #519 holding.
  • LRI Investments first reported a position in Boston Scientific in Q1 2024 and has held it in 10 quarters since.
  • LRI Investments's Boston Scientific position peaked at $691K in Q2 2025.
  • 770 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.